The stock isn't moving? It was in the $7s last month. I'd say there's been decent movement over the last month.
It'll take positive FDA results to reach last summer's highs. Last year money was being passed around at unsustainable levels and everyone was in party mode. I don't see that environment returning anytime soon.
If you're a trader, Anavex is a boring opportunity because of the long time it takes to properly run a trial. If you're an investor, waiting until 2025 or even 2030 to see this through to the end is not a big deal. So far everything seems to be progressing smoothly.
I'd bet that there isn't a single drug that's ever been approved that didn't have some group rallying against it, trying to distort the science or accuse the company of mismanagement.
News 
Market Data 
Discover 
AI
